Page last updated: 2024-08-21

dihydroergotamine and cp 93129

dihydroergotamine has been researched along with cp 93129 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccalini, P; Moskowitz, MA; Nozaki, K1
Castanon, N; Chauveau, J; Chaveau, J; Hen, R; Macor, JE; Moskowitz, MA; Scearce, K; Waeber, C; Yu, XJ1

Other Studies

2 other study(ies) available for dihydroergotamine and cp 93129

ArticleYear
CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
    British journal of pharmacology, 1992, Volume: 106, Issue:2

    Topics: Animals; Animals, Newborn; Capsaicin; Carrageenan; Dihydroergotamine; Formaldehyde; Gene Expression Regulation, Neoplastic; Guinea Pigs; Immunohistochemistry; In Vitro Techniques; Indoles; Meninges; Nasal Mucosa; Proto-Oncogene Proteins c-fos; Pyridines; Pyrroles; Rats; Sulfonamides; Sumatriptan

1992
5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
    Molecular pharmacology, 1996, Volume: 49, Issue:5

    Topics: Animals; Capillary Permeability; Dihydroergotamine; Dipeptides; Mice; Mice, Knockout; Pyridines; Pyrroles; Pyrrolidines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion

1996